25 research outputs found
« Fictions urbaines. Entretien avec Sylvie Blocher et François Daune du collectif Campement Urbain »
Depuis plus de dix ans, le collectif Campement Urbain Ă©labore des dispositifs artistiques permettant dâinventer collecti- vement de nouvelles « fictions urbaines » qui reconfigurent localement lâespace public. Le point de dĂ©part de ces dispositifs est volontairement prĂ©caire : quelques questions envoyĂ©es aux habitants par cartes postales, des ateliers de quartier, lâĂ©laboration dâun projet autour dâun « objet de solitude ». Le sens du dispositif tenant moins Ă son originalitĂ© quâĂ sa capacitĂ© Ă gĂ©nĂ©rer des fictions collectives, construites sur quelques mois ou plusieurs annĂ©es par les habitants du quartier, les associations et les institutions.
En 2001, le projet Je et Nous propose aux habitants des Beaudottes, Ă Sevran, de concevoir un « espace de solitude ». Le projet, menĂ© sur trois ans, se redĂ©finit constamment en fonction des questions quâil soulĂšve : quelle forme architec- turale donner Ă une piĂšce de solitude ? Quel sens peut avoir un espace laĂŻc de recueillement ? Qui gĂšrera le lieu ? Qui gardera les clefs ? Loin de toute utopie moderniste comme de toute forme dâinterventionnisme social, Sylvie Blocher et François Daune, initiateurs du collectif, reviennent ici sur ces interventions singuliĂšres qui redonnent un sens Ă©minemment politique Ă certaines valeurs inactuelles : lâincertitude, la dilapidation du temps, la non productivitĂ©, lâimagination collective, les « trĂ©sors de rien »
Functional Profiling of Transcription Factor Genes in Neurospora crassa.
Regulation of gene expression by DNA-binding transcription factors is essential for proper control of growth and development in all organisms. In this study, we annotate and characterize growth and developmental phenotypes for transcription factor genes in the model filamentous fungus Neurospora crassa We identified 312 transcription factor genes, corresponding to 3.2% of the protein coding genes in the genome. The largest class was the fungal-specific Zn2Cys6 (C6) binuclear cluster, with 135 members, followed by the highly conserved C2H2 zinc finger group, with 61 genes. Viable knockout mutants were produced for 273 genes, and complete growth and developmental phenotypic data are available for 242 strains, with 64% possessing at least one defect. The most prominent defect observed was in growth of basal hyphae (43% of mutants analyzed), followed by asexual sporulation (38%), and the various stages of sexual development (19%). Two growth or developmental defects were observed for 21% of the mutants, while 8% were defective in all three major phenotypes tested. Analysis of available mRNA expression data for a time course of sexual development revealed mutants with sexual phenotypes that correlate with transcription factor transcript abundance in wild type. Inspection of this data also implicated cryptic roles in sexual development for several cotranscribed transcription factor genes that do not produce a phenotype when mutated
Assessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: the challenge ahead.
Lifestyle factors are responsible for a considerable portion of cancer incidence worldwide, but credible estimates from the World Health Organization and the International Agency for Research on Cancer (IARC) suggest that the fraction of cancers attributable to toxic environmental exposures is between 7% and 19%. To explore the hypothesis that low-dose exposures to mixtures of chemicals in the environment may be combining to contribute to environmental carcinogenesis, we reviewed 11 hallmark phenotypes of cancer, multiple priority target sites for disruption in each area and prototypical chemical disruptors for all targets, this included dose-response characterizations, evidence of low-dose effects and cross-hallmark effects for all targets and chemicals. In total, 85 examples of chemicals were reviewed for actions on key pathways/mechanisms related to carcinogenesis. Only 15% (13/85) were found to have evidence of a dose-response threshold, whereas 59% (50/85) exerted low-dose effects. No dose-response information was found for the remaining 26% (22/85). Our analysis suggests that the cumulative effects of individual (non-carcinogenic) chemicals acting on different pathways, and a variety of related systems, organs, tissues and cells could plausibly conspire to produce carcinogenic synergies. Additional basic research on carcinogenesis and research focused on low-dose effects of chemical mixtures needs to be rigorously pursued before the merits of this hypothesis can be further advanced. However, the structure of the World Health Organization International Programme on Chemical Safety 'Mode of Action' framework should be revisited as it has inherent weaknesses that are not fully aligned with our current understanding of cancer biology
Antimicrobial resistance among migrants in Europe: a systematic review and meta-analysis
BACKGROUND: Rates of antimicrobial resistance (AMR) are rising globally and there is concern that increased migration is contributing to the burden of antibiotic resistance in Europe. However, the effect of migration on the burden of AMR in Europe has not yet been comprehensively examined. Therefore, we did a systematic review and meta-analysis to identify and synthesise data for AMR carriage or infection in migrants to Europe to examine differences in patterns of AMR across migrant groups and in different settings. METHODS: For this systematic review and meta-analysis, we searched MEDLINE, Embase, PubMed, and Scopus with no language restrictions from Jan 1, 2000, to Jan 18, 2017, for primary data from observational studies reporting antibacterial resistance in common bacterial pathogens among migrants to 21 European Union-15 and European Economic Area countries. To be eligible for inclusion, studies had to report data on carriage or infection with laboratory-confirmed antibiotic-resistant organisms in migrant populations. We extracted data from eligible studies and assessed quality using piloted, standardised forms. We did not examine drug resistance in tuberculosis and excluded articles solely reporting on this parameter. We also excluded articles in which migrant status was determined by ethnicity, country of birth of participants' parents, or was not defined, and articles in which data were not disaggregated by migrant status. Outcomes were carriage of or infection with antibiotic-resistant organisms. We used random-effects models to calculate the pooled prevalence of each outcome. The study protocol is registered with PROSPERO, number CRD42016043681. FINDINGS: We identified 2274 articles, of which 23 observational studies reporting on antibiotic resistance in 2319 migrants were included. The pooled prevalence of any AMR carriage or AMR infection in migrants was 25·4% (95% CI 19·1-31·8; I2 =98%), including meticillin-resistant Staphylococcus aureus (7·8%, 4·8-10·7; I2 =92%) and antibiotic-resistant Gram-negative bacteria (27·2%, 17·6-36·8; I2 =94%). The pooled prevalence of any AMR carriage or infection was higher in refugees and asylum seekers (33·0%, 18·3-47·6; I2 =98%) than in other migrant groups (6·6%, 1·8-11·3; I2 =92%). The pooled prevalence of antibiotic-resistant organisms was slightly higher in high-migrant community settings (33·1%, 11·1-55·1; I2 =96%) than in migrants in hospitals (24·3%, 16·1-32·6; I2 =98%). We did not find evidence of high rates of transmission of AMR from migrant to host populations. INTERPRETATION: Migrants are exposed to conditions favouring the emergence of drug resistance during transit and in host countries in Europe. Increased antibiotic resistance among refugees and asylum seekers and in high-migrant community settings (such as refugee camps and detention facilities) highlights the need for improved living conditions, access to health care, and initiatives to facilitate detection of and appropriate high-quality treatment for antibiotic-resistant infections during transit and in host countries. Protocols for the prevention and control of infection and for antibiotic surveillance need to be integrated in all aspects of health care, which should be accessible for all migrant groups, and should target determinants of AMR before, during, and after migration. FUNDING: UK National Institute for Health Research Imperial Biomedical Research Centre, Imperial College Healthcare Charity, the Wellcome Trust, and UK National Institute for Health Research Health Protection Research Unit in Healthcare-associated Infections and Antimictobial Resistance at Imperial College London
Surgical site infection after gastrointestinal surgery in high-income, middle-income, and low-income countries: a prospective, international, multicentre cohort study
Background: Surgical site infection (SSI) is one of the most common infections associated with health care, but its importance as a global health priority is not fully understood. We quantified the burden of SSI after gastrointestinal surgery in countries in all parts of the world.
Methods: This international, prospective, multicentre cohort study included consecutive patients undergoing elective or emergency gastrointestinal resection within 2-week time periods at any health-care facility in any country. Countries with participating centres were stratified into high-income, middle-income, and low-income groups according to the UN's Human Development Index (HDI). Data variables from the GlobalSurg 1 study and other studies that have been found to affect the likelihood of SSI were entered into risk adjustment models. The primary outcome measure was the 30-day SSI incidence (defined by US Centers for Disease Control and Prevention criteria for superficial and deep incisional SSI). Relationships with explanatory variables were examined using Bayesian multilevel logistic regression models. This trial is registered with ClinicalTrials.gov, number NCT02662231.
Findings: Between Jan 4, 2016, and July 31, 2016, 13 265 records were submitted for analysis. 12 539 patients from 343 hospitals in 66 countries were included. 7339 (58·5%) patient were from high-HDI countries (193 hospitals in 30 countries), 3918 (31·2%) patients were from middle-HDI countries (82 hospitals in 18 countries), and 1282 (10·2%) patients were from low-HDI countries (68 hospitals in 18 countries). In total, 1538 (12·3%) patients had SSI within 30 days of surgery. The incidence of SSI varied between countries with high (691 [9·4%] of 7339 patients), middle (549 [14·0%] of 3918 patients), and low (298 [23·2%] of 1282) HDI (p < 0·001). The highest SSI incidence in each HDI group was after dirty surgery (102 [17·8%] of 574 patients in high-HDI countries; 74 [31·4%] of 236 patients in middle-HDI countries; 72 [39·8%] of 181 patients in low-HDI countries). Following risk factor adjustment, patients in low-HDI countries were at greatest risk of SSI (adjusted odds ratio 1·60, 95% credible interval 1·05â2·37; p=0·030). 132 (21·6%) of 610 patients with an SSI and a microbiology culture result had an infection that was resistant to the prophylactic antibiotic used. Resistant infections were detected in 49 (16·6%) of 295 patients in high-HDI countries, in 37 (19·8%) of 187 patients in middle-HDI countries, and in 46 (35·9%) of 128 patients in low-HDI countries (p < 0·001).
Interpretation: Countries with a low HDI carry a disproportionately greater burden of SSI than countries with a middle or high HDI and might have higher rates of antibiotic resistance. In view of WHO recommendations on SSI prevention that highlight the absence of high-quality interventional research, urgent, pragmatic, randomised trials based in LMICs are needed to assess measures aiming to reduce this preventable complication
Assessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: the challenge ahead
Lifestyle factors are responsible for a considerable portion of cancer incidence worldwide, but credible estimates from the World Health Organization and the International Agency for Research on Cancer (IARC) suggest that the fraction of cancers attributable to toxic environmental exposures is between 7% and 19%. To explore the hypothesis that low-dose exposures to mixtures of chemicals in the environment may be combining to contribute to environmental carcinogenesis, we reviewed 11 hallmark phenotypes of cancer, multiple priority target sites for disruption in each area and prototypical chemical disruptors for all targets, this included dose-response characterizations, evidence of low-dose effects and cross-hallmark effects for all targets and chemicals. In total, 85 examples of chemicals were reviewed for actions on key pathways/mechanisms related to carcinogenesis. Only 15% (13/85) were found to have evidence of a dose-response threshold, whereas 59% (50/85) exerted low-dose effects. No dose-response information was found for the remaining 26% (22/85). Our analysis suggests that the cumulative effects of individual (non-carcinogenic) chemicals acting on different pathways, and a variety of related systems, organs, tissues and cells could plausibly conspire to produce carcinogenic synergies. Additional basic research on carcinogenesis and research focused on low-dose effects of chemical mixtures needs to be rigorously pursued before the merits of this hypothesis can be further advanced. However, the structure of the World Health Organization International Programme on Chemical Safety âMode of Actionâ framework should be revisited as it has inherent weaknesses that are not fully aligned with our current understanding of cancer biology
Recommended from our members
Assessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: the challenge ahead
Lifestyle factors are responsible for a considerable portion of cancer incidence worldwide, but credible estimates from the World Health Organization and the International Agency for Research on Cancer (IARC) suggest that the fraction of cancers attributable to toxic environmental exposures is between 7% and 19%. To explore the hypothesis that low-dose exposures to mixtures of chemicals in the environment may be combining to contribute to environmental carcinogenesis, we reviewed 11 hallmark phenotypes of cancer, multiple priority target sites for disruption in each area and prototypical chemical disruptors for all targets, this included dose-response characterizations, evidence of low-dose effects and cross-hallmark effects for all targets and chemicals. In total, 85 examples of chemicals were reviewed for actions on key pathways/ mechanisms related to carcinogenesis. Only 15% (13/85) were found to have evidence of a dose-response threshold, whereas 59% (50/85) exerted low-dose effects. No dose-response information was found for the remaining 26% (22/85). Our analysis suggests that the cumulative effects of individual (non-carcinogenic) chemicals acting on different pathways, and a variety of related systems, organs, tissues and cells could plausibly conspire to produce carcinogenic synergies. Additional basic research on carcinogenesis and research focused on low-dose effects of chemical mixtures needs to be rigorously pursued before the merits of this hypothesis can be further advanced. However, the structure of the World Health Organization International Programme on Chemical Safety âMode of Actionâ framework should be revisited as it has inherent weaknesses that are not fully aligned with our current understanding of cancer biology
Notre patrimoine rétroviral
Les donnĂ©es fournies par le sĂ©quençage du gĂ©nome humain montrent que les Ă©lĂ©ments de type rĂ©troviral constituent environ 8 % de l'euchromatine. Lâorigine de ces Ă©lĂ©ments, leur propagation conduisant Ă une organisation en familles, leur structure gĂ©nĂ©tique et lâidentification des domaines fonctionnels des constituants de ces Ă©lĂ©ments sont dĂ©crits. Lâimplication physiologique des HERV (Human Endogenous Retrovirus) est illustrĂ©e Ă travers lâexemple du placenta. Les fonctions des Ă©lĂ©ments de contrĂŽle transcriptionnel (LTR) ainsi que lâimplication possible des protĂ©ines rĂ©trovirales dans la rĂ©sistance Ă lâinfection, lâimmunosuppression, et la diffĂ©renciation cellulaire sont explicitĂ©es. En particulier les donnĂ©es permettant dâimpliquer lâenveloppe du locus ERVWE1 de la famille HERV-W dans le processus de fusion aboutissant Ă la formation du syncytiotrophoblaste sont dĂ©crites. Lâimplication pathologique potentielle des HERV est principalement illustrĂ©e Ă travers lâexpression de la super-famille HERV-K dans les cancers. Plus prĂ©cisĂ©ment, l'association entre la protĂ©ine de rĂ©gulation Rec codĂ©e par HERV-K(HML-2) et le processus de tumorigenĂšse testiculaire est dĂ©veloppĂ©e. La nature causale ou consĂ©cutive de l'expression/rĂ©-expression de sĂ©quences rĂ©trovirales dans dâautres contextes physiopathologiques est discutĂ©e. Pour conclure, le rapport bĂ©nĂ©fice/risque de lâacquisitionpropagation des HERV est examinĂ© Ă la lumiĂšre de lâĂ©volution des espĂšces et au regard du caractĂšre multicopie des familles HERV et de la nature essentiellement multifactorielle des pathologies autoimmunes et cancĂ©reuses
Tobacco Policies at Colleges and Universities Housing PreK â 12 Laboratory Schools: An Exploratory Study
Objective. This study examined the current status of tobacco-/smoke-free campus policies at PreK - 12 laboratory schools and their affiliated colleges/universities. Perceived barriers to passage of tobacco-/smoke-free policies and aspects of the school environment perceived to aid in passage of such polices were also examined. Methods. Data were collected through electronic surveys to administrators of 61 U.S. International Association of Laboratory School members and their affiliated colleges/universities. Information on state tobacco policies was obtained from the National Association of State Board of Educationâs State School Healthy Policy Database on tobacco use. Results. Inconsistencies between college/university tobacco-/smoke-free policies and state board of education guidelines existed. Faculty/staff issues, social issues, and internal policy implementation challenges emerged as the top categories of barriers. Laws and policies, support from key stakeholders, and communication strategies were the strongest aids. Conclusions. There is not a consistent standard of protection offered for PreK - 12 students across the country. Colleges/universities housing laboratory schools may be placing their PreK - 12 students at greater risk of exposure to pro-tobacco influences and secondhand smoke if they are not governed by comprehensive tobacco policies